Across TCGA pan-cancer cohorts, RPL30P15 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL30P15’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where RPL30P15 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL30P15 is over-expressed in tumor.
THCA and KIRC are the cancer types where RPL30P15 tumor–normal differential expression is most reproducible.